Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionLantz Financial LLC
Latest Disclosed Ownership16,744 shares
Latest Disclosed Value $ 2,333,644
Lantz Financial LLC reports 10.35% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 9, 2026 - Lantz Financial LLC filed a 13F-HR form disclosing ownership of 16,744 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,333,644 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 18,677 shares of Gilead Sciences, Inc.. This represents a change in shares of -10.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F GILEAD SCIENCES COM 375558103 16,744 -1,933 -10.35 2,334 1.79 0.4825
2026-01-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 18,677 -1,796 -8.77 2,292 0.88 0.4837
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 20,473 -513 -2.44 2,273 -2.32 0.5029
2025-07-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 20,986 -1,247 -5.61 2,327 -6.62 0.5799
2025-04-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 22,233 -3,367 -13.15 2,491 5.37 0.6818
2025-01-21 2024-12-31 13F GILEAD SCIENCES COM 375558103 25,600 -214 -0.83 2,365 9.24 0.6303
2024-10-15 2024-09-30 13F GILEAD SCIENCES COM 375558103 25,814 894 3.59 2,164 26.62 0.5859
2024-08-07 2024-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 24,920 840 3.49 1,710 -3.06 0.5312
2024-07-10 2024-06-30 13F GILEAD SCIENCES COM 375558103 24,920 840 1,710 0.5312
2024-04-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 24,080 1,470 6.50 1,764 -3.71 0.5676
2024-01-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 22,610 705 3.22 1,832 11.58 0.6615
2023-10-20 2023-09-30 13F GILEAD SCIENCES COM 375558103 21,905 -218 -0.99 1,642 -3.75 0.6532
2023-07-12 2023-06-30 13F GILEAD SCIENCES COM 375558103 22,123 -1,004 -4.34 1,705 -11.11 0.6676
2023-04-10 2023-03-31 13F GILEAD SCIENCES COM 375558103 23,127 -2,711 -10.49 1,919 -13.53 0.7980
2023-01-23 2022-12-31 13F GILEAD SCIENCES COM 375558103 25,838 -702 -2.65 2,218 35.49 1.0089
2022-10-17 2022-09-30 13F GILEAD SCIENCES COM 375558103 26,540 220 0.84 1,637 0.61 0.8518
2022-07-29 2022-06-30 13F GILEAD SCIENCES COM 375558103 26,320 2,857 12.18 1,627 -4.52 0.7343
2022-01-19 2021-12-31 13F GILEAD SCIENCES COM 375558103 23,463 945 4.20 1,704 8.33 0.7847
2021-10-14 2021-09-30 13F GILEAD SCIENCES COM 375558103 22,518 539 2.45 1,573 3.97 0.8064
2021-07-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 21,979 706 3.32 1,513 10.04 0.7777
2021-04-19 2021-03-31 13F GILEAD SCIENCES COM 375558103 21,273 770 3.76 1,375 15.06 0.7822
2021-01-19 2020-12-31 13F GILEAD SCIENCES COM 375558103 20,503 390 1.94 1,195 -5.98 0.7456
2020-10-09 2020-09-30 13F GILEAD SCIENCES COM 375558103 20,113 846 4.39 1,271 -14.24 0.8547
2020-07-22 2020-06-30 13F GILEAD SCIENCES COM 375558103 19,267 -2,610 -11.93 1,482 -9.41 1.0667
2020-04-10 2020-03-31 13F GILEAD SCIENCES COM 375558103 21,877 4,352 24.83 1,636 43.63 1.2819
2020-01-17 2019-12-31 13F GILEAD SCIENCES COM 375558103 17,525 -3,320 -15.93 1,139 -11.29 0.6744
2019-10-18 2019-09-30 13F GILEAD SCIENCES COM 375558103 20,845 1,095 5.54 1,284 -5.59 0.8665
2019-07-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 19,750 85 0.43 1,360 6.42 0.9206
2019-04-22 2019-03-31 13F GILEAD SCIENCES COM 375558103 19,665 19,665 1,278 0.9269
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.